Upfront

Contributed by:

PharmaVOICE Staff

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

Industry at Large

MMRF, Takeda, and CURE Media Join Forces to Support Hiking Team

PV0916_MMRFA team of 20 multiple myeloma patients, caregivers, physicians, nurses, and supporters hiked along Peru’s arduous Inca Trail leading to the ruins of Machu Picchu to raise funds for research and to build awareness around the incurable blood cancer. The Inca Trail trek is the third event for Moving Mountains for Multiple Myeloma (MM4MM), a collaboration between the Multiple Myeloma Research Foundation (MMRF), CURE Media Group, and Takeda that has raised nearly $500,000 to date for critically needed myeloma research.

Editor’s Note: MMRF was founded by
PharmaVOICE 100 Red Jacket honoree Cathy Giusti in 1988.

Takeda and the Crohn’s & Colitis Foundation Partner to Introduce IBD Unmasked

Takeda Pharmaceuticals and the Crohn’s & Colitis Foundation of America launched an international inflammatory bowel disease (IBD) awareness campaign. The centerpiece of the campaign is the Super Hero Samarium, which highlights the strength and resilience of the IBD community, encourages people with Crohn’s disease (CD) or ulcerative colitis (UC) — the two most common types of IBD — to embrace their inner Super Heroes, and empowers patients to have honest and open conversations with their healthcare providers.

Every year, about 70,000 people in the United States are diagnosed with IBD. For the people who have to manage this chronic disease, day-to-day commitments like going to work or carrying on with everyday activities may be challenging. In addition to what can be painful physical symptoms, people with CD or UC can oftentimes feel alone in their experiences; lack of public awareness and perceived stigma surrounding IBD may cause many patients to mask their disease by isolating themselves.(PV)

Awards…

CommonHealth Worldwide Executive Receives Leadership Award
Ogilvy CommonHealth Worldwide, the health behavior change specialists of Ogilvy & Mather, and a WPP company, have announced that Johanna Skilling, executive VP, director of planning in the US, has received the Leadership Award from the PVBLIC Foundation, an innovative nonprofit media organization that harnesses the power of media to drive social change.

ICON and Pfizer Honored as Clinical Research Team of the Year
ICON, a global provider of drug development solutions, and Pfizer have won the Clinical Research Team of the Year award at the inaugural Clinical and Research Excellence (CARE) Awards.

ICON and Pfizer won the award for their achievements in 2015 on two ongoing parallel cardiovascular outcome studies, which will involve about 26,000 patients at 3,000 sites in 35 countries.

Ogilvy & Mather Agencies Win at 2016 Cannes Lions Health
Ogilvy CommonHealth Worldwide took home four Lions Health awards and placed third in the Healthcare Network of the Year category. These Lions Health awards include two of the competition’s highest honors, the Pharma Grand Prix Lion, the Grand Prix for Good (awarded to the network’s DAVID Buenos Aires office), as well as four Gold Lions, six Silver Lions, and five Bronze Lions.

Parexel Wins American Business Award
Parexel has been named Company of the Year – Pharmaceuticals in the 14th Annual American Business Awards, which recognized it for several new services, processes, product innovations, and academic programs in 2015. Parexel also received a Gold Stevie Award for Best Public Relations Event.

eBook
Enhancing the Patient Experience Through mHealth – a Win-Win
Provided by: BBK Worldwide

Podcasts
Pharmacies and Managed Care: Key Stakeholders of the Elevate Provider Network
Provided by: Amerisource Bergen

Optimizing a Rare Disease Asset for Commercialization
Provided by: Cello Health

Overcoming the Business Challenges of Rare Diseases
Provided by: TrialCard

Webinars
Piloting the Queen Mary: The Unique Challenges of Cardiovascular Outcome Studies
Sponsored by: Worldwide Clinical Trials
September 29, 2016

White Papers
Rare Disease: Taking a Different Approach
Provided by: Cello Health

Mars vs. Venus: Men, Women, Trust & Biopharma
Provided by: Health Perspectives Group

Improved Data Quality & Integrity for Faster Regulatory Approvals
Provided by: Medidata

Leverage Your EDC System to Streamline Site Payments
Provided by: Medidata

Speeding Study Start-Up in Multicenter Clinical Trials
Provided by: Schulman IRB

No Patient Left Behind – Connecting Rare Disease Patients to Orphan Drug Manufacturers
Provided by: TrialCard

Posted in:

Post a Comment

You must be logged in to post a Comment.

FEEDBACK